Cerence Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-05-07.
0001628280-26-032139
Item 1A. Risk FactorsCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-08-06.
0001628280-26-054339
Item 1A. Risk FactorsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 4 previous paragraphs and 6 current paragraphs.
4 unchanged; 0 reworded; 2 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (2)
Current report
There can be no assurance that our share repurchase program will be consummated or that we will mitigate dilution posed by share issuances through the repurchase of our common stock.
Current report
Our Board of Directors has authorized share repurchase authority of up to $30 million under our share repurchase program. The amount and timing of stock repurchases under this program are subject to capital availability and consideration of many factors, such as our financial condition, earnings, the impact of dilution from employee stock awards, market conditions, stock price, applicable legal and regulatory requirements and other factors that we deem relevant. There can be no assurance that we will repurchase shares of our common stock under our repurchase program at favorable prices or at all, nor can we provide assurance that the share repurchase program will mitigate dilution posed by share issuance pursuant to employee equity compensation awards. Further, our share repurchases could affect the trading price of our common stock, increase its volatility, or reduce our cash reserves, and it may be suspended, modified, or terminated at any time.